Signs are similar to human disease , including anorexia, fever, and thrombocytopenia.

Results According our statistic result, there were about 35-41 % thrombocytosis in patients with lung cancer.

结果根据我们的统计, 肺癌患者中有35—41%的有血小板升高.

Transfusion was required in 0.34 % , and venous thromboembolism occurred in 0.04 %.

仅0.34%的患者需接受输血, 深静脉血栓的发病率为0.04%.

Acute Pulmonary Thromboembolism: Has Its Evolution Been Redefined?

急性肺血栓栓塞: 是否对它的演进重新给予定义?

Conclusion Improvement of diagnosis pulmonary thromboembolism , early diagnosis and early treatment are important to good result.

结论提高诊断意识, 早期诊断,早期治疗,可获良好结果.

Objective To improve the doctor's knowledge and notice of pulmonary thromboembolism.

目的提高对肺栓塞的认识和警惕性.

Objective To explore Yiqiwenyang-huoxuelishui Therapy ( YHT ) for prevention of acute pulmonary thromboembolism ( APTE ).

目的探讨益气温阳、活血利水法在预防急性肺血栓栓塞 ( APTE ) 的作用及其可行性.

Serum CRP at 7 d after RCSI was close to that before thrombolysis.

术后第7dCRP水平与溶栓前比较差异无统计学意义(P>0.05).

Research tendency of thrombolysis of acute ischemic cerebrovascular disease using traditional Chinese medicine and metabonomic study.

急性缺血性脑血管病的中药溶栓治疗与代谢组学的研究趋势.

Methods 20 cases AMI were analysised with pre-hospital thrombolysis treatment.

方法分析20例急性心肌梗死院前溶栓的结果.

Results After thrombolysis treatment, recanalization patients were 29 recanalization 19.

结果经溶栓治疗后急性心肌梗死患者再通者29例,未通者19例.

Results NDS reduced rapidly after thrombolysis, there was significant difference between two groups ( P < 0.001 ).

结果溶栓后NDS迅速减少, 两组比较差异有统计学意义 ( P<0.001 ).

Mean LVEF was similar in both groups with primary angioplasty and 46 % for those receiving thrombolysis.

平均左室射血分数两组相似,直接血管成形术组是48%,溶栓治疗组是46%.

Thrombolytic ( clot-dissolving ) drugs may be administered. Beta-Blockers alleviate pain and slow the heart rate.

或许可以提供溶 血栓 药物.β阻断剂减轻疼痛并降低心跳速率.

Objective To discuss the effects of target-artery thrombolytic therapy for cerebral embolism.

目的探索动脉靶血管内溶栓治疗脑栓塞的治疗效果.

Killipgroup, 87 cases, 39 cases with direct PCI treatment, 48 cases with thrombolytic treatment.

Killip级 组87例, 其中39例行直接PCI治疗, 48例予溶栓治疗.

Lumbrokinase is hopeful to become a new and effective anticoagulant or thrombolytic agent.

蚓激酶有望成为新的高效溶栓、抗栓药.

These substances with anti-tumor , anti-oxidation , lower pressure, thrombolytic, constipation prevention, prevention of Alzheimer's. prevent osteoporosis effects.

这些物质具有抗肿瘤 、 抗氧化 、 降血压 、 溶血栓 、 预防便秘 、 预防老年痴呆、防止骨质疏松等作用.

Thrombolytic therapy and other treatments for heart attack are more effective the sooner they areattack starts.

在心脏病发作时,溶血和其他的治疗都是开始越早效果越好.

Thrombolytic ( clot-dissolving ) drugs may be administered.

或许可以提供溶 血栓 药物.

Superficial thrombophlebitis remains a common complication of continuous intravenous infusion.

浅表血栓性静脉炎是持续静脉注射的常见并发症.